From ABBV CC: Dropout rate in TURQUOISE-2, where 100% of patients had cirrhosis, was only 2%! (GILD has not yet furnished any data on cirrhotic patients from the ‘ION’ studies.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”